Company: MDCXW
Filing Date: 2025-03-07
Form Type: 253G1
Source: 0001062993-25-004966
Chunk: 239

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-07
Form: 253G1
Chunk 239
---
 during the year ended December 31, 2023 (2022 - $nil). Additional expenses of $736,690 were incurred by RBx on behalf of the Company. The Company paid $970,740 to RBx during the year ended December 31, 2023 (2022 - $nil). The total amount of accounts payable to RBx was $165,950 as of December 31, 2023 (December 31, 2022 - $nil).

<div align='center'>F-44</div>

Key management personnel compensation during the years ended December 31, 2023 and 2022 comprised:

|                       |     | December 31, 
         2023 |     | December 31, 
 2022         |
|:----------------------|:----|-------------:|:----|:-------------|
|                       |     |            $ |     | $            |
| Salaries and benefits |     |      585,712 |     | -            |
| Share-based payments  |     |      123,701 |     | -            |
| Total                 |     |      709,413 |     | -            |

14. Capital management

The Company's capital management objectives are to maintain financial flexibility in order to pursue its strategy of organic growth and to provide returns to its shareholders. The Company defines capital as the aggregate of its share capital and borrowings. Borrowings consists of the issued and outstanding note payable, convertible promissory notes and preferred share liabilities.

Total managed capital is as follows:

|               |     | December 31, 
         2023 |     | December 31, 
         2022 |
|:--------------|:----|-------------:|:----|-------------:|
|               |     |            $ |     |            $ |
| Borrowings    |     |            - |     |   12,380,890 |
| Share capital |     |   19,835,839 |     |      194,538 |
|               |     |   19,835,839 |     |   12,575,428 |

The Company manages its capital structure in accordance with changes in economic conditions. In order to maintain or adjust its capital structure, the Company may elect to issue or repay financial liabilities, issue shares, repurchase shares, pay dividends or undertake any other activities as deemed appropriate under the specific circumstances. The Company is not subject to any externally imposed capital requirements.

15. Financial